S1 Biopharma is developing first-in-class drugs for the treatment of sexual dysfunction and hypoactive sexual desire disorder (HSDD) in both women and men. The company’s non-hormonal therapies work uniquely by restoring the natural balance of neurotransmitters in the brain.

Pharmaceutical

S1 Biopharma

Nicolas G. Sitchon

John F. Kaufmann

The leadership team at S1 Biopharma has a history of working in finance and investment. The team includes a finance manager, finance director, and analyst with experience in mergers and acquisitions and equity capital markets. The team is also educated, with degrees from universities and colleges.

Leadership Team

About

Team members

Other teams at S1 Biopharma

Board of Directors

CEO and Executive Team